List of works - Alessandro Loglio

8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

scientific article published on 7 February 2018

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

scientific article published on 02 July 2018

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B

scientific article published on 19 June 2018

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir

scientific article published on 07 January 2019

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.

scientific article published on 28 June 2017

Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs).

scientific article published on January 2017

Hepatitis D - how is the fight against this foe going?

scientific article published on 06 February 2019

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

scientific article published on 02 January 2020

IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients

scientific article

Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

scientific article published on 07 September 2018

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy

scientific article published on 12 August 2019

Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients

scientific article published on 07 December 2018

Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?

scientific article published on 17 January 2018

Tenofovir alafenamide as a Rescue Therapy in a Cirrhotic HBV Patient with a Hystory of Fanconi Syndrome and Multidrug Resistance: A Case Report.

scientific article published on September 2017

The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV Caucasian cirrhotics on long-term oral therapy

scientific article published on 16 April 2020

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study